Structure Therapeutics

GPCR · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 28 days ago

Previous year: -$1.17

-86.3%

Research and Development Expenses

$20M

General and Administrative Expenses

$11M

Cash, Cash Equivalents and Short-Term Investments

Previous year: $26.1M

+1691.0%

Free Cash Flow

-$23.1M

Previous year: -$12.1M

+90.7%

Total Assets

$482M

Previous year: $97.8M

+392.6%

Loading...

Structure Therapeutics

Unlock previous datapoints

Upgrade

Structure Therapeutics

Unlock previous datapoints

Upgrade

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.33B

P/E Ratio

-25.69

Sector

N/A

Industry

N/A

52-Week High

$93.5

52-Week Low

$14.1

Research and Development Expenses

$20M

General and Administrative Expenses

$11M

Cash, Cash Equivalents and Short-Term Investments

$467M

Share-Based Compensation Expense

$1.9M

Products

Get in Touch

Resources

Structure Therapeutics

Structure Therapeutics

Structure Therapeutics

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics